MTOR and cancer: The participation of TCTP in the following cancer-promoting pathways has been demonstrated: the mTOR pathway and cell cycle progression, DNA repair and genome stability, antagonism to tumor suppressor p53 and anti-apoptotic activity, maintenance of ‘stemness’ in cancer cells, promotion of EMT and involvement in metastasis, and development of radio- and chemoresistance in cancer cells.